RJA
DNMR

Raymond James & Associates’s Danimer Scientific, Inc. DNMR Stock Holding History

Raymond James & Associates’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$20.1K Sell
1,105
-46
-4% -$803 ﹤0.01% 3947
2024
Q2 		$27.8K Sell
1,151
-340
-23% -$10.6K ﹤0.01% 3859
2024
Q1 		$65K Sell
1,491
-275
-16% -$11.4K ﹤0.01% 3780
2023
Q4 		$72K Sell
1,766
-156
-8% -$8.48K ﹤0.01% 3674
2023
Q3 		$159K Buy
1,922
+176
+10% +$16K ﹤0.01% 3512
2023
Q2 		$166K Sell
1,746
-363
-17% -$46.6K ﹤0.01% 3531
2023
Q1 		$291K Buy
2,109
+461
+28% +$42.1K ﹤0.01% 3260
2022
Q4 		$118K Sell
1,648
-658
-29% -$62.2K ﹤0.01% 3604
2022
Q3 		$272K Buy
2,306
+251
+12% +$44.7K ﹤0.01% 3246
2022
Q2 		$375K Buy
2,055
+181
+10% +$32.9K ﹤0.01% 3080
2022
Q1 		$439K Buy
1,874
+475
+34% +$95.9K ﹤0.01% 3144
2021
Q4 		$477K Buy
1,399
+217
+18% +$120K ﹤0.01% 3112
2021
Q3 		$772K Sell
1,182
-211
-15% -$155K ﹤0.01% 2750
2021
Q2 		$1.4M Sell
1,393
-196
-12% -$195K ﹤0.01% 2361
2021
Q1 		$2.4M Buy
1,589
+1,151
+263% +$1.87M ﹤0.01% 1893
2020
Q4 		$412K Buy
+438
New +$235K ﹤0.01% 2943

Other funds holding DNMR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Raymond James & Associates's DNMR Position: Q3 2024 in Review

Raymond James & Associates reduced its Danimer Scientific, Inc. (DNMR) stake by 4% in Q3 2024, selling an estimated $803 and leaving 1,105 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3947.

Raymond James & Associates first reported a position in DNMR in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.4M in Q1 2021. 113 funds tracked by Wall St. Rank hold DNMR as of Q3 2024.

  • Raymond James & Associates held 1,105 shares of Danimer Scientific, Inc. worth $20.1K as of Q3 2024.
  • Raymond James & Associates sold 46 Danimer Scientific, Inc. shares in Q3 2024, an estimated $803.
  • Danimer Scientific, Inc. made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3947 holding.
  • Raymond James & Associates first reported a position in Danimer Scientific, Inc. in Q4 2020 and has held it in 16 quarters since.
  • Raymond James & Associates's Danimer Scientific, Inc. position peaked at $2.4M in Q1 2021.
  • 113 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.